Additionally, multivariate analysis revealed a significant association only in the patients with NSCLC expressing PD-L1 TPS ≥ 50% (HR = 0.30, 95% CI: 0.12–0.76, p = 0.011; Table 3). Here, CD274 is linked to non-small cell lung carcinoma.